These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18217270)

  • 21. Cost implications of wastage of drugs: focus on insulin.
    Costa B; Belmonte M
    Pharmacoeconomics; 1994 Jul; 6(1):1-4. PubMed ID: 10147349
    [No Abstract]   [Full Text] [Related]  

  • 22. Update in diabetes management.
    Cranwell-Bruce LA
    Medsurg Nurs; 2009; 18(1):51-3; quiz 54. PubMed ID: 19331300
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of inhaled insulin in the treatment of type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2008; 22(6):420-9. PubMed ID: 18413196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Basal insulin in discussion--clinical and health economics aspects].
    Middeke M
    Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S99; discussion S124-6. PubMed ID: 18686223
    [No Abstract]   [Full Text] [Related]  

  • 25. Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes.
    Guimarães C; Marra CA; Colley L; Gill S; Simpson S; Meneilly G; Queiroz RH; Lynd LD
    Diabetes Technol Ther; 2009 Sep; 11(9):567-73. PubMed ID: 19764835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Need for U-40 insulin.
    Rabin J
    JAMA; 1979 Mar; 241(12):1230. PubMed ID: 153979
    [No Abstract]   [Full Text] [Related]  

  • 27. What's fueling the biotech engine-2007.
    Aggarwal S
    Nat Biotechnol; 2008 Nov; 26(11):1227-33. PubMed ID: 18997759
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmaceutical product withdrawal: attributions of blame and its impact on trust.
    Bunniran S; McCaffrey DJ; Bentley JP; Bouldin AS
    Res Social Adm Pharm; 2009 Sep; 5(3):262-73. PubMed ID: 19733827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality by design - Spray drying of insulin intended for inhalation.
    Maltesen MJ; Bjerregaard S; Hovgaard L; Havelund S; van de Weert M
    Eur J Pharm Biopharm; 2008 Nov; 70(3):828-38. PubMed ID: 18755270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled insulin for the early detection of lung cancer.
    Lehrer S
    Med Hypotheses; 2008 Oct; 71(4):615-6. PubMed ID: 18602221
    [No Abstract]   [Full Text] [Related]  

  • 31. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a regulation, etc. for medical oxygen administration?
    AAOHN J; 2009 Jan; 57(1):7-8. PubMed ID: 19248743
    [No Abstract]   [Full Text] [Related]  

  • 33. The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics.
    Levin P
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():66-75. PubMed ID: 18577158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Perspectives in the inhalative administration of drugs].
    Haidl P; Scheuch G
    Pneumologie; 2008 Jun; 62(6):330-6. PubMed ID: 18535977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shadow pricing and the art of profiteering from outdated therapies.
    Rathore AS; Shereef F
    Nat Biotechnol; 2019 Mar; 37(3):217-220. PubMed ID: 30809025
    [No Abstract]   [Full Text] [Related]  

  • 37. When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective.
    Huang SM; Temple R; Xiao S; Zhang L; Lesko LJ
    Clin Pharmacol Ther; 2009 Nov; 86(5):475-9. PubMed ID: 19844224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. To eat or not to eat? Food safety in the United States.
    Galson SK
    J Am Diet Assoc; 2009 Jul; 109(7):1142. PubMed ID: 19559125
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmaceutical industry in pediatric drug development: partners and collaborators with academia and the FDA.
    Mulberg AE
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):711-3. PubMed ID: 18955888
    [No Abstract]   [Full Text] [Related]  

  • 40. Securing the US pharmaceutical supply.
    Somberg JC
    Am J Ther; 2008; 15(3):197. PubMed ID: 18496255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.